Results 191 to 200 of about 4,684 (246)

Pharmaceutical access in Brazil: challenges and opportunities. [PDF]

open access: yesGlobal Health
Ruas CM   +5 more
europepmc   +1 more source

Transforming trade for vaccine equity: Policy gaps and barriers. [PDF]

open access: yesPLOS Glob Public Health
Pepperrell T   +3 more
europepmc   +1 more source

Policies to promote affordability and access across the life cycle of costly new drugs.

open access: yesBMJ
Kruja K   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Compulsory Licensing of Patents

Pharmaceutical Patent Analyst, 2022
Compulsory licensing (CL) is a mechanism made by the government to provide balance between the monopoly right holders and the third person with public interest by ensuring the ease availability of the patented products at reasonable rate. This paper discusses the background criteria for getting CL in India as per the Indian Patent Act, 1970 starting ...
Narayanasamy Kumutha   +2 more
openaire   +2 more sources

Thailand and the Compulsory Licensing of Efavirenz

New England Journal of Medicine, 2007
In November 2006, Thailand's Ministry of Public Health issued a compulsory license for efavirenz, which permits the Thai government to import generic efavirenz from India. Dr.
openaire   +2 more sources

Optimal Patents with Compulsory Licensing

Journal of Political Economy, 1982
This paper examines the use of compulsory lincensing as a policy to combat the monopoly problem associated with the patent system. It introduces the notion of an optimal patent--one where the patent life and the licensing royalty rate are both determined optimally.
openaire   +1 more source

Home - About - Disclaimer - Privacy